SEC Form 4 · accession 0001140361-16-089715
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry Ward Wolff
Officer — Exec VP & CFO
Period of report
Dec 12, 2016
Accepted (ET)
Dec 14, 2016 · 8:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Dec 12, 2015 | F | 13,778 | $3.05 | D | 206,829 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to satisfy the Reporting Person's tax withholding obligation upon the vesting and issuance of RSUs.
- F2Includes 12,500 and 25,000 shares subject to RSUs granted on December 11, 2014 and December 8, 2015 respectively, which will be issued as such units vest in accordance with their terms.
- F3Includes an aggregate of 4,904 shares acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan on October 31, 2015, April 30, 2016 and October 31, 2016.